Pricing Log in Create free account

Actinium Pharmaceuticals, Inc. (ATNM) vs Dogwood Therapeutics, Inc (DWTX)

Actinium Pharmaceuticals, Inc. and Dogwood Therapeutics, Inc are both Biotechnology companies. Actinium Pharmaceuticals, Inc. and Dogwood Therapeutics, Inc are of similar size ($40.9M and $39.8M). Dogwood Therapeutics, Inc has negative trailing earnings, so its P/E is not meaningful; Actinium Pharmaceuticals, Inc. trades at 3.9×. Actinium Pharmaceuticals, Inc. has the higher net margin (32.2% vs 0.00%) and the higher return on invested capital (0.00% vs −41.2%). Across the 12 metrics below, Actinium Pharmaceuticals, Inc. leads on 7 and Dogwood Therapeutics, Inc on 5.

Valuation

Metric ATNM DWTX Biotechnology median
P/E 3.94 n/m 10.60
P/S 1.27 n/m 9.40
P/B 1.47 0.66 2.13
Price to free cash flow n/m n/m 25.18
EV/EBITDA 0.78 n/m 0.66
EV/Sales 0.23 n/m 9.02
Earnings yield 25.35% (678.03%) (32.88%)
Free cash flow yield (52.14%) (33.54%) (23.13%)

Profitability

Metric ATNM DWTX Biotechnology median
Gross margin 98.71% — 68.51%
Operating margin 27.20% 0.00% 0.00%
Net margin 32.18% 0.00% 0.00%
Free cash flow margin (66.16%) 0.00% 0.00%
Return on equity 45.86% (143.45%) (51.96%)
Return on assets 21.92% (40.68%) (46.06%)
Return on invested capital 0.00% (41.22%) 0.00%

Growth

Metric ATNM DWTX Biotechnology median
Revenue growth (TTM) 2,731.18% — 6.76%
EPS growth (last fiscal year) 14.17% 43.05% 29.88%
Revenue growth, 5-year CAGR — — 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric ATNM DWTX Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 4.08 3.89 4.97
Net debt to EBITDA 1.35 0.23 1.01

Dividend

Metric ATNM DWTX Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric ATNM DWTX Biotechnology median
Market cap 40.87m 39.75m 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack